Ark Clinical Research

Tustin, California 92780

0 studies enrolling now · 2 studies all time

What they study most

COVID-19 Prevention, Respiratory Syncytial Virus

Studies at this site

• A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age — Completed
• A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults — Completed